Improved or sustained GL-3 clearance from renal cells of patients who had Fabry disease and underwent long-term agalsidase β therapya
Renal Cell Type | No. Evaluated at Month 6 | No. (%) with Score of 0 | No. Evaluated at Month 54b | No. (%) with Score of 0 |
---|---|---|---|---|
Capillary endothelial cells | 49 | 47 (96) | 8 | 8 (100) |
Glomerular endothelial cells | 35 | 35 (100) | 5 | 5 (100) |
Mesangial cells | 35 | 34 (97) | 5 | 5 (100) |
Interstitial cells | 48 | 43 (90) | 7 | 5 (71) |
Noncapillary endothelial cells | 44 | 40 (91) | 6 | 6 (100) |
Noncapillary smooth muscle cells | 43 | 0 (0) | 6 | 0 (0) |